cas 6639-87-8|| where to buy 6-nitroquinoxaline

Produktname:6-nitroquinoxaline

IUPAC Name:6-nitroquinoxaline

: CAS：6639-87-8; Molekulare Formel：C8H5N3O2; Reinheit：95%

: Katalognummer：CM100001; Molekulargewicht：175.15

Packungseinheit	Verfügbarer Vorrat	Preis($)
CM100001-5g	in stock	ȤǠ
CM100001-10g	in stock	ƅǠȤ
CM100001-25g	in stock	ǺǺǠ

Anfrage: sales@chemenu.com

Nur für den Einsatz in Forschung und Entwicklung..

Anfrage-Formular

Chemische Bezeichnung

CAS-Nummer

Menge*

Erforderliche Spezifikationen*
(Gehalt %, Materialqualität etc.)

Name des Ansprechpartners*

E-Mail des Ansprechpartners*

Meanwhile I'd like to create a registered account on CHEMENU.COM with the above email.

I'd like to receive emails related to products with similar structures to 6639-87-8 regularly via the above email.

Zusätzliche Hinweise

Verification code*

refresh

Produkt-Details

: CAS-Nr.:6639-87-8; Molekulare Formel:C8H5N3O2; Schmelzpunkt:-; SMILES-Code:C1=CC2=NC=CN=C2C=C1[N+](=O)[O-]; Dichte:1.437g/cm3

: Katalognummer:CM100001; Molekulargewicht:175.15; Siedepunkt:; Mdl-Nr.:MFCD00462822; Lagerung:Store at room temperature.

Category Infos

: Quinoxalines; Quinoxalines, also known as benzopyrazines, are heterocyclic compounds containing a ring complex consisting of a benzene ring and a pyrazine ring. It has isomerism with other naphthalene compounds such as quinazoline, phthalazine, cinnamine, etc. Fusion N-heterocyclic compounds are widely used as valuable entities for the expansion of important pharmacological agents and are considered to be an advantageous scaffold material. Among the numerous fused N-heterocyclic compounds, cinnoline, quinoxaline and quinazoline are important pharmacological agents. In medicinal chemistry, these N-heterocyclic compounds have a wide range of biological properties and can be used as synthetic intermediates, potential drug candidates and chemical probes.

Column Infos

: Quinoxalines

Product Other Information

Synthesis Method

6-Nitroquinoxaline can be synthesized in a two-step process. The first step involves the condensation of o-nitroaniline with ethyl acetoacetate in the presence of an acid catalyst to form the intermediate 2-methyl-6-nitroquinoxaline. This intermediate can then be reduced with sodium borohydride to yield 6-nitroquinoxaline.